DK1390022T3 - Anvendelse af 4-(2-fluorphenyl)-6-methyl-2-(1-piperazinyl)thieno (2,3-D)pyrimidin til behandling af smerte - Google Patents

Anvendelse af 4-(2-fluorphenyl)-6-methyl-2-(1-piperazinyl)thieno (2,3-D)pyrimidin til behandling af smerte

Info

Publication number
DK1390022T3
DK1390022T3 DK02771681T DK02771681T DK1390022T3 DK 1390022 T3 DK1390022 T3 DK 1390022T3 DK 02771681 T DK02771681 T DK 02771681T DK 02771681 T DK02771681 T DK 02771681T DK 1390022 T3 DK1390022 T3 DK 1390022T3
Authority
DK
Denmark
Prior art keywords
thieno
piperazinyl
fluorophenyl
pyrimidine
pain
Prior art date
Application number
DK02771681T
Other languages
English (en)
Inventor
Robert William Gristwood
David Cavalla
Hazel Judith Bardsley
Original Assignee
Arachnova Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arachnova Therapeutics Ltd filed Critical Arachnova Therapeutics Ltd
Application granted granted Critical
Publication of DK1390022T3 publication Critical patent/DK1390022T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK02771681T 2001-05-22 2002-05-21 Anvendelse af 4-(2-fluorphenyl)-6-methyl-2-(1-piperazinyl)thieno (2,3-D)pyrimidin til behandling af smerte DK1390022T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0112494.0A GB0112494D0 (en) 2001-05-22 2001-05-22 New therapeutic use
PCT/GB2002/002388 WO2002094249A1 (en) 2001-05-22 2002-05-21 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine for the treatment of pain

Publications (1)

Publication Number Publication Date
DK1390022T3 true DK1390022T3 (da) 2007-08-13

Family

ID=9915109

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02771681T DK1390022T3 (da) 2001-05-22 2002-05-21 Anvendelse af 4-(2-fluorphenyl)-6-methyl-2-(1-piperazinyl)thieno (2,3-D)pyrimidin til behandling af smerte

Country Status (15)

Country Link
EP (1) EP1390022B1 (da)
JP (1) JP3749519B2 (da)
KR (1) KR20040012808A (da)
CN (1) CN1230176C (da)
AT (1) ATE359769T1 (da)
AU (1) AU2002307872B2 (da)
BR (1) BR0209956A (da)
CA (1) CA2447465A1 (da)
DE (1) DE60219616T2 (da)
DK (1) DK1390022T3 (da)
ES (1) ES2283598T3 (da)
GB (1) GB0112494D0 (da)
PT (1) PT1390022E (da)
SI (1) SI1390022T1 (da)
WO (1) WO2002094249A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
DE602004005814T2 (de) 2003-01-13 2008-01-10 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
WO2004062623A2 (en) * 2003-01-13 2004-07-29 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
EP1539181B1 (en) 2003-04-04 2007-06-27 Dynogen Pharmaceuticals Inc. Method of treating lower urinary tract disorders
EP1795196A3 (en) * 2003-04-04 2008-02-06 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60146891A (ja) * 1984-01-05 1985-08-02 Mitsubishi Chem Ind Ltd 〔２，３−ｄ〕チエノピリミジン誘導体およびその塩

Also Published As

Publication number Publication date
WO2002094249A1 (en) 2002-11-28
AU2002307872B2 (en) 2004-10-07
BR0209956A (pt) 2004-04-20
JP2004531557A (ja) 2004-10-14
ES2283598T3 (es) 2007-11-01
ATE359769T1 (de) 2007-05-15
CN1230176C (zh) 2005-12-07
GB0112494D0 (en) 2001-07-11
CA2447465A1 (en) 2002-11-28
EP1390022A1 (en) 2004-02-25
JP3749519B2 (ja) 2006-03-01
DE60219616T2 (de) 2008-01-31
KR20040012808A (ko) 2004-02-11
DE60219616D1 (de) 2007-05-31
CN1511029A (zh) 2004-07-07
SI1390022T1 (sl) 2007-08-31
PT1390022E (pt) 2007-05-31
EP1390022B1 (en) 2007-04-18

Similar Documents

Publication Publication Date Title
ATE433978T1 (de) 5,7-diaminopyrazolo 4,3-d pyrimidine zur verwendung in der behandlung von bluthochdruck
ATE362474T1 (de) Pyrazolo(1,5-a)pyrimidine als hemmstoffe cyclin- abhängiger kinasen
NO20023527L (no) Pyrido(2,3-d)pyrimidin-2,7-diamin kinaseinhibitorer
MA26881A1 (fr) 5-alkyl-pyrido [2,3-d]pyrimidines inhibitrices de tyrosine-kinases.
NO20031852D0 (no) Pyrimidin-2,4,6-trion metalloproteinase inhibitorer
PT1235830E (pt) Compostos de pirrolo¬2,3-d|pirimidina como inibidores das proteina cinases
EA200500721A1 (ru) Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
ATE359079T1 (de) Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
NO20020662D0 (no) Pyrimidin-2,4,6-trion metalloproteinase inhibitorer
LT3808743T (lt) Živ replikaciją slopinantys pirimidinai
EP1401840A4 (en) NEW 4-AMINO-5,6-SUBSTITUTED THIOPHENO 2,3 D | PYRIMIDINE
MXPA03010810A (es) Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
BRPI0516242A (pt) compostos tieno-pirimidina tendo atividade fungicida
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
AU2003268424A1 (en) Treatment of pain by inhibition of p38 map kinase
BR0307369A (pt) Uso de 4-(2-fluoro-fenil)-6-metil-2-(1-piperazinil)-tieno (2,3-d)-pirimidina para o tratamento de incontinência urinária
DK1390022T3 (da) Anvendelse af 4-(2-fluorphenyl)-6-methyl-2-(1-piperazinyl)thieno (2,3-D)pyrimidin til behandling af smerte
ATE345345T1 (de) Thieno(2,3-d)pyrimidine mit kombinierter lh und fsh agonistischen wirkung
DE60326585D1 (de) 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidin bei der behandlung von funktionalen darmstörungen
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
GB0216027D0 (en) New therapeutic use
DE60207280D1 (de) GLYCINSUBSTITUIERTE THIENO[2,3-d]PYRIMIDINE MIT KOMBINIERTER LH- UND FSH-AGONISTISCHER WIRKUNG
PL373247A1 (en) Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
GB0316115D0 (en) New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno [2,3-d]pyrimidine
GB0304648D0 (en) New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine